Erin Miller, Marketing Director
FOR IMMEDIATE RELEASE
Journal of Nutrition Publishes Ganeden’s 21st Study
Research shows GanedenBC30 Supports Digestive and Immune Health in Healthy Seniors
CLEVELAND, OH (May 7, 2015) – Ganeden, the maker of the patented probiotic strain GanedenBC30 (Bacillus coagulans GBI-30, 6086), announced today that the highly anticipated 21st study on GanedenBC30 and the senior population is now published in the prestigious Journal of Nutrition.
The study was a double-blind, placebo controlled cross-over study of 36 male and female subjects 65-80 years old, who were all in general good health and free of any GI illness. The study consisted of two 28 day treatment periods, with a 21 day wash out period in the middle. Research showed that when 1 billion CFU of GanedenBC30 was consumed daily, there was in increase in the population of Faecalibacterium prausnitzii, a strain of beneficial bacteria that is important for Gastrointestinal (GI) health (low levels have been associated with GI issues); and also demonstrated a reduction in IL-10, an important cytokine that helps reduce inflammation throughout the body.
“Seniors have natural changes to the GI and immune system that are unrelated to illness, making them an ideal healthy population to study in order to show the benefits of a probiotic,” says David Keller, VP of Scientific Operations at Ganeden. “This study in healthy adults supports both digestive and immune health claims for GanedenBC30, and has helped us better understand how GanedenBC30 can help with the effects of aging in the gut.”
In addition to the human trial, an in vitro study was conducted (previously published in Anaerobe) utilizing samples from the above population, to look at the synergistic effects of GanedenBC30 and prebiotics. Results showed that there was an increase in short chain fatty acids (SCFA), (which are important for GI health), in subjects consuming prebiotics after GanedenBC30 versus when prebiotics were consumed alone.
The Journal of Nutrition (JN/J Nutr) publishes peer-reviewed original research papers covering all aspects of experimental nutrition in humans and other animal species; special articles such as reviews and biographies of prominent nutrition scientists; and issues, opinions, and commentaries on controversial issues in nutrition. A premier journal in its field, JN has been in circulation since 1928. JN is an official monthly publication of the American Society for Nutrition (ASN).
Click here to read the complete study.
Introducing GanedenBC30 (Bacillus coagulans GBI-30, 6086), Ganeden Biotech’s patented probiotic ingredient that can be found in more than 100 leading food, beverage and companion animal products around the world. Unlike most other probiotic strains, GanedenBC30 is a spore-former which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by over 20 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage or companion animal product that is baked, boiled, frozen or squeezed….including all hot or refrigerated beverages! For more information, please visit GanedenBC30.com.
Ganeden is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, non-GMO, highly stable probiotic ingredient. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden and licensing opportunities visit GanedenProbiotics.com.
About The Journal of Nutrition:
The Journal of Nutrition (JN/J Nutr) publishes peer-reviewed original research papers covering all aspects of experimental nutrition in humans and other animal species; special articles such as reviews and biographies of prominent nutrition scientists; and issues, opinions, and commentaries on controversial issues in nutrition. Supplements are frequently published to provide extended discussion of topics of special interest. A premier journal in its field, JN has been in circulation since 1928. JN is an official monthly publication of the American Society for Nutrition (ASN). Membership in ASN includes a subscription to the online version of JN. JN publishes original research reported by authors in over 50 countries and is distributed worldwide to more than 1000 institutions, in addition to personal subscribers and ASN members. For more information please visit JN.Nutrition.org